The CBT Board of Directors

Peter Richardson
Born 1954. M.A. Ph.D., Managing Director. Having completed an undergraduate degree in Biochemistry at the University of Oxford, Peter Richardson completed a PhD at the Department of Clinical Biochemistry in Cambridge. He subsequently held a number of research positions in Cambridge and Gottingen, Germany, before becoming a lecturer in the Cambridge University Department of Pharmacology in 1989. His research prior to the founding of CBT was mainly in the areas of neurochemistry and adenosine action. In 2001, Peter was one of the founders of CBT and served as Chief Scientific Officer until April 2005.

Martin Nicklasson
Born 1955. Has a degree in Pharmacy, and a Ph.D. in Pharmaceutical Science. Since 1985 he has been an associate professor at the Faculty of Pharmacy at Uppsala University. Martin Nicklasson joined Biovitrum from a position as member of the executive management of AstraZeneca Plc. as Executive Vice President and head of Global Marketing and CEO of AstraZeneca AB. Has previously held a number of leadership positions within AstraZeneca; including President of Astra Pain Control AB and President of Astra Hässle AB, Executive Vice President of the Astra and AstraZeneca Gastrointestinal Franchise in addition to Executive Vice President of Global Drug Development in AstraZeneca. Martin has also held research leadership positions at Kabi Pharmacia.

Management team